Drugs / ARRY-142886
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00085787 | Jun 2004 → Feb 2007 | cancer of unknown primary site | Array BioPharma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARRY-142886 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00085787 ↗ |
| Action | Inhibit | “ARRY-142886, MEK inhibitor; oral” NCT00085787 ↗ |
| Route | Oral | “ARRY-142886, MEK inhibitor; oral” NCT00085787 ↗ |